Glucocorticoids
13
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
46%
6 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Acute Effects of Ultra-processed Versus Unprocessed Foods on Glucocorticoid Secretion in Healthy Individuals
Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake
Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients
Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease
Short-course High-dose Prednisone and Dexamethasone in Children With ITP
CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
SporTRIA Study: A Multicentre Trial for Excretion Kinetics of Triamcinolone Acetonide Following Sport Related Intra-articular Injections in Knees; Definitions of the Washout Periods
CST1-Guided Oral Glucocorticoids Management for CRSwNP
Optimization of Glucocorticoid Taper Strategies for SLE-ITP
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy
Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
Corticosteroid Reduction in COPD
Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus